Prurigo Nodularis Latest Advances
Find the Latest Research About Prurigo Nodularis
Last Updated: 06/30/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 788 publications
Prurigo nodularis en plaque resolved after a loading dose of nemolizumab.
Journal: Proceedings (Baylor University. Medical Center)
Published: June 10, 2026
Acute T-cell leukemia/lymphoma presenting with leukemia cutis mimicking prurigo nodularis.
Journal: JAAD case reports
Published: May 06, 2026
Safety, Pharmacokinetics, and Efficacy of 1.5% Ruxolitinib Gel (HDM3010) in Adult Patients with Prurigo Nodularis: A Phase I/II, Randomized, Double-Blind, Vehicle-Controlled Multicenter Clinical Trial.
Journal: Dermatology and therapy
Published: April 10, 2026
Swiss Practice Recommendations for Chronic Prurigo Including Prurigo Nodularis.
Journal: International journal of dermatology
Published: April 02, 2026
The patient journey in prurigo nodularis: what lies ahead.
Journal: Expert opinion on biological therapy
Published: April 01, 2026
Correction: Dupilumab Reduces Pruritus in Clinically Distinct Dermatologic Diseases: Data from Clinical Trials on Atopic Dermatitis, Prurigo Nodularis, and Chronic Spontaneous Urticaria.
Journal: Dermatology and therapy
Published: March 19, 2026
Prurigo nodularis in children in Finland from 1995 to 2024: a nationwide registry study.
Journal: The British journal of dermatology
Published: March 17, 2026
Dupilumab subgroup responder analysis: a post hoc analysis from LIBERTY PRIME and PRIME2 in prurigo nodularis.
Journal: The Journal of dermatological treatment
Published: March 11, 2026
Dupilumab Treatment Provides Multidimensional Benefits in Patients with Prurigo Nodularis.
Journal: Dermatology and therapy
Published: March 03, 2026
The State of the Art in Chronic Prurigo Nodularis.
Journal: Dermatology and therapy
Published: February 28, 2026
The Impact of Nemolizumab Treatment on the Systemic Inflammatory Indices in Patients With Prurigo Nodularis: A Retrospective Study With a Small Sample Size.
Journal: International journal of dermatology
Published: February 23, 2026
Targeting the neuroimmune axis in prurigo nodularis: a critical appraisal of the nemolizumab trials.
Targeting the neuroimmune axis in prurigo nodularis: a critical appraisal of the nemolizumab trials.
Journal: Expert opinion on biological therapy
Published: February 19, 2026
Last Updated: 06/30/2026